Other related studies demonstrated that coexpression of MYC and TGF-α enhances the development of HCC through the disruption of the pRb/EF2 pathway and that TGF-α might function as a survival factor for neoplastic cells, thereby accelerating the neoplastic process (143). The gene discussed is TGFA; the disease is hepatocellular carcinoma.